Inhibitory effect of p53 upregulated modulator of apoptosis targeting siRNA on hypoxia/reoxygenation-induced cardiomyocyte apoptosis in rats

Cardiology (Switzerland)

Volumn 122, Issue 2, 2012, Pages 93-100

  Tu, Shuo ^a   Liu, Zhuo Qi ^a   Fu, Jing Jing ^a   Zhu, Wei Feng ^a   Luo, Da Ya ^a   Wan, Fu Sheng ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiomyocyte; Hypoxia reoxygenation; p53 upregulated modulator of apoptosis; RNA interference

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; PUMA PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL ENLARGEMENT; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REPERFUSION INJURY; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84863085675     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000338701     Document Type: Article

References (31)

1. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DC: Apopto-sis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315: 856-859.
2. Letai A: PUMA strikes Bax. J Cell Biol 2009; 185: 189-190.
3. Yee KS, Vousden KH: Contribution of membrane localization to the apoptotic activity of PUMA. Apoptosis 2008; 13: 87-95.
4. Yu J, Yue W, Wu B, Zhang L: PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res 2006; 12: 2928-2936.
5. Sun Q, Sakaida T, Yue W, Gollin SM, Yu J: Chemosensitization of head and neck cancer cells by PUMA. Mol Cancer Ther 2007; 6: 3180-3188.
6. Reimertz C, Kögel D, Rami A, Chittenden T, Prehn JH: Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 2003; 162: 587-597.
7. Wu B, Qiu W, Wang P, Yu H, Cheng T, Zam-betti GP, Zhang L, Yu J: p53 independent induction of PUMA mediates intestinal apop-tosis in response to ischaemia-reperfusion. Gut 2007; 56: 645-654.
8. Fu JJ, Wan FS: Promoting apoptotic effect of p53 up-regulated modulator of apoptosis. Chem Life 2010; 30:286-290.
9. Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP, Zhang L, Yu J: PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008; 2:576-583.
10. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, Vinten-Jo-hansen J: Progressively developed myocar-dial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6: 279-290.
11. Buja LM: Myocardial ischemia and reperfu-sion injury. Cardiovasc Pathol 2005; 14:170-175.
12. Fu JJ, Duan R, LI H, Wan FS: Study on PUMA-mediated hypoxia- reoxygenation-in-duced rat cardiomyocyte apoptosis. Chin Phamacol Bull 2011; 27:312-316.
13. Nickson P, Toth A, Erhardt P: PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res 2007; 73: 48-56.
14. LI H, Wan FS, Yang W, Luo DY: Effects of taurine on the apoptosis of cardiomyocyte and its mechanism. J Nanchang Univ (Nat Sci) 2004; 2:170-173.
15. Yu J, Zhang L, Hwang P, Kinzler KW, Vogel-stein B: PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7: 673-682.
16. Nakano K, Vousden K: PUMA, a novel pro-apoptotic gene, is induced by p53. Mol Cell 2001; 7: 683-694.
17. Han J, Flemington C, Houghton A, Gu Z, Zambetti GP, Lutz RJ, Zhu L, Chittenden T: Expression of Bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and suvival signals. Proc Natl Acad Sci USA 2001; 98:11318-11323.
18. Bu YQ, Yang ZM, Lan H, Lei Z, Li LG, Zhou SF: Effects of siRNA-mediated NFBD1 silencing on cellular growth and apoptosis in HeLa cells. Chin J Biochem Mol Biol 2008; 24: 943-949.
19. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chitten-den T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP: PUMA is an essential mediator of p53-dependent and p53-independent apoptotic pathways. Cancer Cell 2003; 4:321-328.
20. Gallenne T, Gautier F, Oliver L, Hervouet E, Noël B, Hickman JA, Geneste O, Cartron PF, Vallette FM, Manon S, Juin P: Bax activation by the BH3-only protein PUMA promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 2009; 185: 189-191.
21. Yu J, Zhang L: PUMA, a potent killer with or without p53. Oncogene 2009; 27:S71-S83.
22. Zhang SY, Ge YL, Luo DY, Tian RH: Small interfering RNAs directed against VEGF gene inhibit proliferation of breast cancer cells in vitro and in vivo. Chin J Biochem Mol Biol 2007; 23: 68-73.
23. Sahu NK, Shilakari G, Nayak A, Kohli DV: Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr Pharm Biotechnol 2007; 8:291-304.
24. Watts JK, Deleavey GF, Damha MJ: Chemically modified siRNA: tools and applications. Drug Discov Today 2008; 13: 842-855.
25. Gopalakrishnan B, Wolff J: siRNA and DNA transfer to cultured cells. Methods Mol Biol 2009; 480:31-52.
26. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA: Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98:9742-9747.
27. De Rosa G, La Rotonda MI: Nano and micro-technologies for the delivery of oligonucle-otides with gene silencing properties. Molecules 2009; 14:2801-2823.
28. Fluiter K, Mook OR, Baas F: The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence. Methods Mol Biol 2009; 487: 189-203.
29. Toth A, Jeffers JR, Nickson P, Min JY, Morgan JP, Zambetti GP, Erhardt P: Targeted deletion of PUMA attenuates cardiomyocyte death and improves cardiac function during ischemia reperfusion. Am J Physiol Heart Circ Physiol 2006; 291:H52-H60.
30. Azfer A, Niu J, Rogers LM, Adamski FM, Ko-lattukudy PE: Activation of endoplasmic re-ticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol 2006; 291:1411-1420.
31. Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P: Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 2007; 7:205-218.